Sciclone Pharmaceuticals 10K 2011 Annual report | SCLN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AB, Abstral, ACE, AdriamycinTM, advisory, Aggrastat, aim, al, Ambien, angioplasty, angiotensin, anticonvulsant, arbitration, arisen, ASC, augment, Austria, banker, Barrett, Belgium, binding, BioAlliance, Biopharmaceutical, bipolar, broadened, captionEmanuel, Cardio, cardiology, cardiovascular, choice, clarified, Codification, congestive, coronary, curtail, curtailment, DaunoblastinaTM, delinquent, depakine, diazepam, disagreement, disorder, distract, EBITDA, EMA, EndoxanTM, EP, epileptic, escrow, estate, EstracytTM, exhausted, FarlutalTM, Finland, Footnote, forma, formula, France, Germany, Greece, Hangzhou, heart, highest, HoloxanTM, hypertension, hypnotic, infarction, inhibitor, insomnia, intervention, interventional, Ireland, Iroko, kg, Kingdom, lamotrigine, Language, legacy, lesser, LeucovorinTM, levetiracetam, Loramyc, Lotter, Luxembourg, Mark, MEDA, MesnaTM, MethotrexateTM, metric, midsize, Minsheng, moderate, MRP, Mutual, myocardial, nonfinancial, nonowner, NovaMed, olanzapine, Orexo, Orion, oxcarbazepine, paper, passed, payout, PerenamTM, persuasive, Peter, Pfizer, phenobarbital, Portugal, premium, pro, prolonged, qualitative, quantitative, quantity, quetiapine, rationalizing, remeasure, remittance, rendered, Renegotiation, reorganizational, residence, retired, RMB, RSU, RulideTM, SA, Sanofi, sodium, Spain, Stilnox, surcharge, Sweden, symposia, tangible, theEmanuelaction, TheEmanuellawsuit, toContingent, topiramate, Tramadol, transition, Tritace, unaudited, unidentified, unified, unissued, unnecessary, unprofitable, urological, variability, variation, weaker, western, Winthrop, XatralTM, XBRL

Removed: accompanied, acquiror, adequately, administer, advanced, analog, analytical, avoid, BeadTM, bulk, BVdU, characterize, charged, cisplatin, classify, CODM, commence, commitment, commonly, complement, compound, conference, confirm, consisting, dacarbazine, dean, deposit, device, die, discrete, discretionary, Distributorship, document, dosing, dramatically, dropout, earlier, embolizing, emerge, epidemic, execute, expecting, expenditure, Farmacetiche, Farmadeutiche, fight, Finally, flu, formulation, frequency, gamma, genotype, greatly, Guangzhou, guarantor, halted, HCC, hypervascularized, IIb, inception, inconclusive, Institutional, invoiced, involvement, load, Maker, marketable, mixed, modest, nausea, observation, optimal, PDUFA, pipeline, point, poor, prepaid, presently, prove, Qualifying, quickly, RBV, relapsed, releasing, respond, responded, ribavirin, Riunite, Rome, royalty, satisfied, schedule, Schmid, seasonal, seasonality, secrete, seminar, Singapore, spending, stability, statistical, strategic, substantive, supplement, supportive, sustained, SVR, threatening, timeline, treat, treating, unforeseen, unsatisfactory, varying, virological, vomiting, white, woodman, zadaxin®

Sciclone Pharmaceuticals (SCLN) Inactive 10-K2011 FY Annual report

Content analysis